Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2NNJ
|
||||
| Drug Name |
6-(4-chlorobenzyl)-7-neopentyl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL250589
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H19ClN4
|
||||
| Canonical SMILES |
CC(C)(C)Cn1c(Cc2ccc(Cl)cc2)cc3cnc(nc13)C#N
|
||||
| InChI |
InChI=1S/C19H19ClN4/c1-19(2,3)12-24-16(8-13-4-6-15(20)7-5-13)9-14-11-22-17(10-21)23-18(14)24/h4-7,9,11H,8,12H2,1-3H3
|
||||
| InChIKey |
NMPKSVSAPWRTCT-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.